osimertinib,tepotinib
astrazeneca,merck
['lung', 'osimertinib', 'tepotinib']
excellent presentation by #esmo22. met amplification is common in egfr+ lung ca progressing on osimertinib. adding (but not changing to) tepotinib to osimertinib looks v promising. 
Associate Professor and Medical Oncologist at University of Ottawa, Past President of Lung Cancer Canada, and a cricket fan!